Investor Alert - Cybin: Changing the Mental Healthcare Experience

Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a singl …

January 17, 2022
Request Investor InfoRequest Investor Info
Cybin

On a mission to revolutionize mental healthcare

Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a single-minded goal to dramatically improve patient outcomes versus currently available pharmacotherapies.

Their work includes the development of new drug molecules, with a focus on optimizing treatment outcomes through innovative drug delivery systems, concurrent therapy regimens, and technology-driven patient analytics.

For more information on Cybin Inc. (NEO: CYBN, NYSE AMERICAN: CYBN) please click the request investor info button.

stock market
stock picks
stocks
stocks to buy

You might also like

Harvest HHII: How Can Investors Combine International Growth With Monthly Income?
ETFs
July 28, 2026

Harvest HHII: How Can Investors Combine International Growth With Monthly Income?

This is some text inside of a div block.
Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?
Finance
July 23, 2026

Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?

This is some text inside of a div block.
Brompton Funds
ETFs
July 23, 2026

Brompton Funds: Enhanced Multi-Asset Income ETF - BMAX

BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

This is some text inside of a div block.
Subscribe and receive the investor Info